| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 195.69B | 164.35B | 134.49B | 122.75B | 124.45B | 104.93B |
| Gross Profit | 156.01B | 137.11B | 118.16B | 113.09B | 110.77B | 92.40B |
| EBITDA | 60.01B | 55.14B | 47.33B | 40.99B | 31.71B | 26.44B |
| Net Income | 43.30B | 36.55B | 31.57B | 27.21B | 20.62B | 16.86B |
Balance Sheet | ||||||
| Total Assets | 12.01T | 12.16T | 11.58T | 11.04T | 12.21T | 12.27T |
| Cash, Cash Equivalents and Short-Term Investments | 756.29B | 1.34T | 962.78B | 1.20T | 2.70T | 2.61T |
| Total Debt | 825.59B | 1.77T | 1.33T | 258.26B | 3.08T | 3.57T |
| Total Liabilities | 10.83T | 11.08T | 10.44T | 10.05T | 11.12T | 11.11T |
| Stockholders Equity | 1.18T | 1.08T | 1.14T | 989.63B | 1.09T | 1.17T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 123.08B | 100.38B | 30.59B | 3.59B | 44.34B |
| Operating Cash Flow | 0.00 | 127.46B | 104.19B | 32.26B | 7.36B | 46.76B |
| Investing Cash Flow | 0.00 | -309.49B | -556.16B | -483.58B | 32.95B | -264.21B |
| Financing Cash Flow | 0.00 | 574.75B | 207.08B | -1.04T | 58.81B | 1.73T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.27T | 19.77 | ― | 2.04% | 18.33% | 36.24% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥943.01B | 8.76 | ― | 2.10% | 2.96% | 39.35% | |
66 Neutral | ¥1.27T | 8.94 | 8.24% | 3.06% | 14.78% | 36.69% | |
65 Neutral | ¥448.76B | 14.75 | ― | 1.50% | 21.64% | 43.65% | |
64 Neutral | ¥1.15T | 11.66 | ― | 2.00% | 26.28% | 29.23% | |
62 Neutral | ¥1.53T | 14.17 | ― | 3.04% | 10.07% | 32.63% |